Lava Therapeutics

Developer of novel gamma delta T-cell engagers to treat cancer

placeS Hertogenbosch, North Brabant, Netherlands calendar_todayFounded 2016 groups15 employees language lavatherapeutics.com

Registered entities

Social engagement

Social engagement: 10.2K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Sanofi Ventures, Pureos Bioventures, Redmile Group, Ysios Capital; 1 has since exited.

Investor typeCountShare
Venture capital655%
Private equity19%
Other / undisclosed436%
Coming soon